We conduct scientific research into the development of ovarian cancer. We also investigate all kinds of related issues, such as cancer risks and the opinion of patients. Below is a list of our studies that we have published in scientific journals.
Please note that all articles are written in scientific English.
Last update: May 10th, 2024
Removal of fallopian tubes and ovaries
- How many have had the fallopiant tubes and ovaries removed?: https://pubmed.ncbi.nlm.nih.gov/27430397/
Removal of fallopian tubes with delayed removal of ovaries
- Acceptability of removal of fallopian tubes with delayed removal of ovaries: https://pubmed.ncbi.nlm.nih.gov/24582866/
- The opinion of patients and professionals: https://pubmed.ncbi.nlm.nih.gov/25560807/
- TUBA study protocol: https://pubmed.ncbi.nlm.nih.gov/26286255/
- Acceptability and safety of removal of the fallopian tubes: https://pubmed.ncbi.nlm.nih.gov/29735278/
- TUBA-WISP II study protocol (NCT04294927): https://pubmed.ncbi.nlm.nih.gov/37045546/
- Thesis 'Prevention and etiology of serous cancer of the female genital tract' by Miranda Steenbeek: Thesis
- Thesis 'Optimizing risk-reducing care for women at high inherited risk for ovarian cancer: The potential of the fallopian tubes' by Majke van Bommel: Thesis
- TUBA-WISP II: Is een tubectomie met uitgestelde ovariectomie oncologisch veilig?: TUBA-WISP II: is een tubectomie met uitgestelde ovariëctomie oncologisch veilig? - NTVO (in Dutch, English summary available)
Cancer risks
- Estimating the safety of removal of fallopian tubes with delayed removal of ovaries: https://pubmed.ncbi.nlm.nih.gov/27159752/
- Peritoneal cancer after removal of fallopian tubes and ovaries: https://pubmed.ncbi.nlm.nih.gov/29315498/
- 'STIC' at preventive surgery and the risk of peritoneal cancer afterwards: https://pubmed.ncbi.nlm.nih.gov/35302882/
- Contraceptives and cancer risks among BRCA carriers: https://pubmed.ncbi.nlm.nih.gov/36383189/
Early detection of ovarian cancer
- CA125 to detect ovarian cancer in women at increased familial risk: https://pubmed.ncbi.nlm.nih.gov/28143870/
- TP53 as biomarker for early detection: https://pubmed.ncbi.nlm.nih.gov/28637689/
- Mutation analysis along the Mullerian tract to detect ovarian cancer: pubmed.ncbi.nlm.nih.gov/36384753/
Decision making
- Satisfaction with strategies to prevent ovarian cancer: https://pubmed.ncbi.nlm.nih.gov/21656744/
- Factors influencing decision making: https://pubmed.ncbi.nlm.nih.gov/30479086/
- Development of a decision aid: https://pubmed.ncbi.nlm.nih.gov/29281161/
- Recommendations and choices for BRCA carriers: https://pubmed.ncbi.nlm.nih.gov/29466291/
- Evaluation of the decision aid: https://pubmed.ncbi.nlm.nih.gov/34456057/
Quality of life
- Self-compassion, physical fitness and menopausal symptoms after removal of fallopian tubes and ovaries: https://pubmed.ncbi.nlm.nih.gov/29290209/
- Demoralization after removal of the ovaries: https://pubmed.ncbi.nlm.nih.gov/28279121/
- Impact of medical choices on quality of life: https://pubmed.ncbi.nlm.nih.gov/26299336/
- Menopause-related quality of life (first results of TUBA study): https://pubmed.ncbi.nlm.nih.gov/34081085/
- Sexual functioning (first results of WISP study (NCT02760849)) - in progress
- Cancer worry among BRCA mutation carriers: https://pubmed.ncbi.nlm.nih.gov/34997316/
Pathology
- Role of the fallopian tubes in the origin of ovarian cancer: https://pubmed.ncbi.nlm.nih.gov/28007588/
- Removal of the fallopian tubes to reduce ovarian cancer risk: https://pubmed.ncbi.nlm.nih.gov/25586903/
- Does ovarian cancer start in the fallopian tubes?: https://pubmed.ncbi.nlm.nih.gov/29676714/
- Recommendations for diagnosing 'STIC': https://pubmed.ncbi.nlm.nih.gov/34850262/
- Consensus based recommendations for diagnosing 'STIC': https://pubmed.ncbi.nlm.nih.gov/36939551/
Cardiovascular disease
- Cardiovascular risk among BRCA carriers: https://pubmed.ncbi.nlm.nih.gov/27451331/
- Impact of BRCA mutation on cardiovascular risk: https://pubmed.ncbi.nlm.nih.gov/24529552/
- Atherosclerosis after removal of the ovaries: https://pubmed.ncbi.nlm.nih.gov/33229237/
Genetics
- BRCA mutation testing in ovarian cancer patients: https://pubmed.ncbi.nlm.nih.gov/27209246/
- Family history and risk of BRCA mutation: https://pubmed.ncbi.nlm.nih.gov/23975082/
- Feasibility of testing all ovarian cancers on BRCA mutations: https://pubmed.ncbi.nlm.nih.gov/31076742/
- Chance of finding a BRCA mutation in various types of ovarian cancer: https://pubmed.ncbi.nlm.nih.gov/34702566/
- European Reference Network to improve access to diagnosis, treatment and provision of healthcare for patients with rare genetic tumour risk syndromes - more information on: www.genturis.eu